Male hypogonadism is a clinical and biochemical diagnosis. A provider looks for compatible symptoms or physical signs alongside consistently low testosterone levels. Neither symptoms nor one low laboratory result can establish the diagnosis alone.
Primary hypogonadism begins in the testicles. When the testicles produce too little testosterone, the pituitary gland usually releases more luteinizing hormone, or LH, in an effort to increase production. Follicle-stimulating hormone, or FSH, may also rise when sperm-producing tissue is impaired. The typical pattern is low testosterone with elevated LH, elevated FSH, or both.
Secondary hypogonadism begins in the hypothalamus or pituitary gland. The hypothalamus signals the pituitary, and the pituitary releases LH and FSH to stimulate testosterone and sperm production in the testicles. When that signaling weakens, testosterone falls while LH and FSH remain low or inappropriately normal. A normal LH value may be abnormal in context because the pituitary should increase LH when testosterone is low.
Some men have a mixed pattern involving impaired testicular function and reduced brain-to-testicle signaling. Age, chronic illness, medication use, and other health conditions can blur the usual laboratory patterns. A provider must interpret testosterone, LH, and FSH together with symptoms, medical history, and physical findings before assigning an individual diagnosis.
When clinical and laboratory findings support low testosterone, LH and FSH help identify where hormone signaling has broken down.
Testosterone treatment can suppress sperm production regardless of category. Men who want biological children should discuss fertility before starting therapy and review Optima Tyler’s TRT, fertility, and enclomiphene resources with a qualified provider. Lab patterns guide evaluation, but symptoms, examination findings, medications, and medical history determine the diagnosis.
Testosterone results require clinical context. Levels can vary with time of day, sleep, acute illness, calorie restriction, heavy training, medication use, and normal biological fluctuation. Laboratory methods add another source of variation, particularly near the lower limit of an assay’s reference range.
A clinician may review collection timing, recent illness, medications, and factors that affect testosterone binding when interpreting an unexpected or borderline result. Sex hormone-binding globulin and calculated free testosterone can sometimes clarify whether total testosterone reflects available testosterone. A qualified provider should decide which tests are appropriate for an individual patient.
A clinician uses targeted testing to identify where testosterone signaling has changed and whether another condition may explain the result. The exact panel depends on symptoms, medical history, medications, and the initial testosterone measurements.
Luteinizing hormone and follicle-stimulating hormone help separate primary from secondary hypogonadism. High LH or FSH with low testosterone supports impaired testicular function. Low or inappropriately normal LH and FSH suggest reduced signaling from the hypothalamus or pituitary.
Sex hormone-binding globulin and free testosterone can clarify borderline or inconsistent total testosterone results. Changes in body weight, thyroid function, liver health, aging, and some medications can alter sex hormone-binding globulin and make total testosterone less representative of available testosterone.
A clinician may check prolactin when low testosterone occurs with low or normal LH. Elevated prolactin can suppress pituitary signaling and may prompt further evaluation. Ferritin and transferrin saturation can identify iron overload, which can affect the pituitary or testes.
Thyroid testing can identify thyroid disorders that cause fatigue, sexual symptoms, or altered sex hormone-binding globulin. Glucose or A1C testing can assess metabolic conditions associated with low testosterone. Kidney and liver tests may identify chronic illness that affects hormone production or interpretation.
Laboratory testing cannot screen fully for sleep restriction or sleep apnea, so a clinician usually evaluates sleep through history and additional testing when indicated. Training history and nutrition also provide useful context. Excessive exercise, inadequate recovery, or insufficient energy intake may temporarily suppress testosterone, while ordinary exercise does not replace evaluation for persistent symptoms or confirmed deficiency.
Several health and lifestyle factors can temporarily suppress testosterone or produce similar symptoms. Sleep restriction, untreated sleep disorders, acute illness, inadequate calorie intake, and substantial weight changes can affect hormone signaling. Certain medications, including opioids and glucocorticoids, may also contribute. A provider can review these factors alongside symptoms and other laboratory results.
Exercise requires careful interpretation. Resistance training or intense activity can cause a brief rise in testosterone after a workout, but habitual exercise does not reliably correct persistent testosterone deficiency. Excessive training can have the opposite effect when inadequate recovery, sleep loss, or insufficient energy intake accompanies it.
Low testosterone can also make exercise harder. Fatigue, reduced strength, low mood, and low motivation may limit activity, while reduced activity can affect body composition and metabolic health. Difficulty maintaining an exercise routine therefore does not prove that someone needs to train harder.
A reversible contributor can coexist with primary or secondary hypogonadism. Finding one changes what a provider may address first, but it does not exclude an underlying testicular or hypothalamic-pituitary problem. Persistent symptoms and concerning testosterone results require clinical evaluation rather than lifestyle assumptions alone.
Pituitary evaluation may become relevant when low testosterone appears with low or inappropriately normal LH and FSH. That secondary hypogonadism pattern suggests that the hypothalamus or pituitary may not be sending enough hormonal signal to the testes. A pituitary MRI may warrant discussion when testosterone is very low, prolactin remains elevated, or testing suggests deficiencies in other pituitary hormones.
Symptoms can strengthen the case for imaging or specialist assessment. New visual changes, loss of peripheral vision, persistent severe headaches, or unexplained nipple discharge may point toward a pituitary disorder. Sudden visual loss or a severe new headache may warrant urgent medical assessment rather than routine follow-up.
An endocrinology or urology referral may also be appropriate when laboratory results conflict, the cause remains unclear, or fertility planning affects treatment choices. A known pituitary condition, prior brain radiation, head trauma, or evidence of iron overload may also support referral.
Low or normal LH does not automatically require imaging. Obesity, acute illness, certain medications, sleep problems, and inadequate energy intake can temporarily suppress hypothalamic and pituitary signaling. A clinician considers those factors alongside the broader laboratory pattern and symptoms before deciding whether imaging or referral may be useful. These criteria provide general education and cannot determine whether a specific person needs imaging or specialist care.
Fertility goals should shape the treatment discussion before a man starts therapy. Exogenous testosterone can suppress the hormonal signals that support sperm production, sometimes reducing sperm counts substantially. A provider may therefore ask about plans for biological children and consider a semen analysis before recommending treatment.
Primary hypogonadism often reflects testicular damage or dysfunction. Because the testes may respond poorly even when LH and FSH are elevated, sperm production can remain impaired. The underlying cause and any remaining testicular function influence whether fertility treatment or sperm retrieval may be feasible.
Secondary hypogonadism involves inadequate signaling from the hypothalamus or pituitary. The testes may retain some capacity to produce testosterone and sperm when a provider can address the cause or restore hormonal stimulation. That potential varies, so low or normal LH and FSH do not guarantee preserved fertility.
Men who want to preserve or restore fertility should discuss timing, semen testing, and future family plans with a qualified provider. Optima Tyler offers additional fertility and enclomiphene resources for general education. Those resources cannot determine which approach fits an individual diagnosis.
Confirmed primary hypogonadism usually shifts the treatment discussion toward direct testosterone replacement because damaged testes may not respond adequately to signals that stimulate natural testosterone production. A provider will consider symptoms, fertility plans, contraindications, and monitoring needs before recommending treatment. Optima Tyler’s TRT resources explain the available approaches in more detail.
Secondary hypogonadism can create additional options because the testes may retain some ability to produce testosterone and sperm. A provider may first address an identified pituitary, medication-related, or reversible cause. For men who want children, the discussion may include treatments intended to support the body’s own hormonal signaling. Optima Tyler’s enclomiphene and fertility resources cover those considerations.
Exogenous testosterone can suppress sperm production, so fertility goals should be discussed before treatment begins. Men with impaired fertility may also need evaluation by an endocrinologist or reproductive urologist. Diagnosis alone does not determine a specific medication, dose, or protocol. A clinician must interpret the cause, symptoms, laboratory findings, and reproductive goals together.
Laboratory results cannot establish hypogonadism or identify its cause on their own. Testosterone measurements vary with the assay, laboratory reference range, and biological changes between days. Abnormal binding protein levels can also make total testosterone harder to interpret, which may prompt a provider to consider free testosterone in context.
Timing and health status can temporarily alter results. Testosterone usually peaks earlier in the day, while acute illness, sleep restriction, inadequate calorie intake, and excessive training can suppress a measurement. A result collected under those conditions may not reflect a person’s usual hormone status.
A clinical diagnosis requires compatible symptoms and a coherent pattern across related findings such as testosterone, LH, and FSH. Providers also consider medications, medical history, physical findings, and possible reversible contributors before assigning a cause.
This article provides general educational context. A qualified provider must interpret individual results and determine whether further testing, specialist referral, or treatment is appropriate.
What is the difference between primary and secondary hypogonadism?
Primary hypogonadism originates in the testes and usually produces low testosterone with elevated LH and FSH. Secondary hypogonadism reflects reduced hypothalamic or pituitary signaling, so testosterone is low while LH and FSH remain low or inappropriately normal.
Can hypogonadism be temporary?
Yes. Acute illness, sleep restriction, inadequate nutrition, certain medications, and excessive training can temporarily suppress testosterone. A provider must interpret testosterone findings alongside symptoms and possible reversible contributors before confirming male hypogonadism.
Does secondary hypogonadism affect fertility differently than primary hypogonadism?
Secondary hypogonadism may leave the testes capable of producing sperm if hormonal signaling can be restored. Primary hypogonadism involves testicular dysfunction, so sperm production may remain impaired despite increased hormonal stimulation. Individual fertility potential requires semen analysis and specialist evaluation.
Why can testosterone results vary?
Testosterone can change with sleep, illness, nutrition, medication use, physical stress, and time of day. A clinician interprets the result with symptoms, health history, and related laboratory findings rather than treating one number as a complete diagnosis.
When should I see an endocrinologist?
Specialist evaluation may be appropriate when low testosterone accompanies low or normal LH, elevated prolactin, very low testosterone, unexplained infertility, or suspected pituitary disease. Headaches, visual changes, or other neurologic symptoms warrant prompt medical assessment. A clinician can determine whether pituitary testing, imaging, or another referral is appropriate.
Accurate classification of hypogonadism should come before treatment because the underlying cause shapes both fertility planning and the treatment path. Secondary hypogonadism may leave options for restoring hormonal signaling and supporting fertility, while primary testicular failure often narrows the discussion toward direct testosterone treatment, which can suppress sperm production.
A qualified provider can interpret symptoms, laboratory patterns, fertility goals, and medical history together. For next steps, review Optima Tyler’s TRT, fertility, and enclomiphene resources and discuss the options with your provider before starting or changing treatment.